Extended Data Fig. 8: Level of utilization of genetic support among targets.
From: Refining the impact of genetic evidence on clinical success
As for Fig. 3, but grouped by target instead of T-I pair. Thus, the denominator for each cell is the number of targets with at least one genetically supported indication, and each target counts towards the numerator if at least one genetically supported indication has reached phase I. See Fig. S9 for the same analyses restricted to drugs with a single known target.